Cite
HARVARD Citation
Lucas, A. et al. (2014). BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high‐risk pancreatic cancer screening and pancreatic cancer cohorts. Cancer. 120 (13), pp. 1960-1967. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lucas, A. et al. (2014). BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high‐risk pancreatic cancer screening and pancreatic cancer cohorts. Cancer. 120 (13), pp. 1960-1967. [Online].